Abstracts - faqs.org

Abstracts

Biological sciences

Search abstracts:
Abstracts » Biological sciences

Novel arylpyrazole compounds selectively modulate glucocorticoid receptor regulatory activity

Article Abstract:

A series of arylpyrazole compounds, which specifically bind the glucocorticoid receptor (GR), selectively modulates GR-regulated biological functions in preadipocyte, preosteoblast, and lung epithelial cell lines. Subtle differences in ligand chemistry can profoundly influence the transcriptional regulatory activity of GR, and that endogenous genes bearing natural glucocortidcoid receptor elements (GREs) are especially sensitive detectors of these differences.

Author: Yamamoto, Keith R., Meijsing, Sebastiaan H., Pantoja, Carlos, Jen-Chywan Wang, Shah, Nilesh, Ho, Joseph D., Scanaln, Thomas S.
Publisher: Cold Spring Harbor Laboratory Press
Publication Name: Genes & Development
Subject: Biological sciences
ISSN: 0890-9369
Year: 2006
Ligand binding (Biochemistry), Chemical properties, Pyrazoles

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression

Article Abstract:

The composition and function of regulatory complexes at two NFkappaB-responsive genes is compared to investigate the determinants of promoter-specific gene regulation by the glucocorticoid receptor (GR). Proinflamatory genes such as IL-8 mRNA synthesis was repressed by GR at a post-initiation step, demonstrating that promoter proximal regulatory sequences assemble complexes that impact early and late stages of mRNA synthesis.

Author: Yamamoto, Keith R., Luecke, Hans F.
Publisher: Cold Spring Harbor Laboratory Press
Publication Name: Genes & Development
Subject: Biological sciences
ISSN: 0890-9369
Year: 2005
Gene mutations, Gene mutation, Nucleotide sequence, Base sequence, Messenger RNA

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Identification of C. elegans DAF-12-binding sites, response elements, and target genes

Article Abstract:

Intracellular receptor DAF -12 regulates dauer formation and development age and affects Caenorhabditis elegans life span. A procedure for multiple rounds of selection and amplification that yielded fragments bearing DAF-12-binding sites is developed beginning with C. elegans genomic DNA.

Author: Yamamoto, Keith R., Antebi, Adam, Shostak, Yuriy, Gilst, Marc R. Van
Publisher: Cold Spring Harbor Laboratory Press
Publication Name: Genes & Development
Subject: Biological sciences
ISSN: 0890-9369
Year: 2004
Biological Product (except Diagnostic) Manufacturing, Drugs, Deoxyribonucleic Acid, DNA, Caenorhabditis elegans, Binding sites (Biochemistry), Active sites (Biochemistry)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, Corticosteroids, Glucocorticoids
Similar abstracts:
  • Abstracts: The glucocorticoid receptor is required for stress erythropoiesis. Glucocorticoid receptor function in hepatocytes is essential to promote postnatal body growth
  • Abstracts: A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts. Getting downstream without a Raft
  • Abstracts: Isolation and sequencing of a temperate transducing phage for Pasteurella multocida. Impact of phages on two-species bacterial communities
  • Abstracts: The Rho/Rac-family guanine nucleotide exchange factor VAV-1 regulates rhythmic behaviors in C. elegans. Structural basis of ligand activation in a cyclic nucleotide regulated potassium channel
  • Abstracts: Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament assembly. Can 1000 reviews be wrong? Actin, alpha-catenin, and adherens junctions
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.